PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Respiratory Medicine, Graduate School of Medical Sciences, Kumamoto University, Japan. Electronic address: y-tomita@kumadai.jp.\', \'Laboratory of Stem Cell and Neuro-Vascular Biology, Genetics and Developmental Biology Center, National Heart, Lung, and Blood Institute, National Institutes of Health, United States.\', \'Laboratory of Clinical Pharmacology and Therapeutics, Faculty of Pharmaceutical Sciences, Sojo University, Japan; Department of Medical Information Sciences and Administration Planning, Kumamoto University Hospital, Japan.\', \'Department of Respiratory Medicine, Graduate School of Medical Sciences, Kumamoto University, Japan.\']
?:citedBy
  • -1
?:creator
?:doi
  • S0264-410X(20)31086-010.1016/j.vaccine.2020.08.045
?:doi
?:hasPublicationType
?:journal
  • Vaccine
is ?:pmid of
?:pmid
?:pmid
  • 32863070
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.863
?:rankingScore_hIndex
  • 159
?:title
  • BCG vaccine may generate cross-reactive T cells against SARS-CoV-2: In silico analyses and a hypothesis.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all